Bausch + Lomb Corporation (BLCO)
Makes contact lenses, eye drops, and surgical equipment for eye care
$16.43+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+21.7%
The outlook
BLCO is trading at $16.43, positioned in the middle of its 52-week range and above both its 50- and 200-day moving averages, suggesting a stable uptrend. Analysts lean Buy with an average target implying roughly 10% upside from current levels. Overall sentiment leans bullish based on the data snapshot.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 11 analysts
Price trendAbove its 50- & 200-day averages
52-week range57% of the way from its 52-week low to high
Price targetAvg target +10% vs current price
Analyst price target
~12-month · 11 analysts$18.14average target+10.4% vs now
Now $16.43
Low $16.00High $21.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.86B
52-wk high
$18.92
52-wk low
$13.09
50-day avg
$15.89
200-day avg
$16.30
Trailing P/E
—